Mulligan Seamus 4
4 · Jazz Pharmaceuticals plc · Filed Jun 12, 2023
Insider Transaction Report
Form 4
Mulligan Seamus
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2023-06-08−4,500→ 0 totalExercise: $81.76Exp: 2023-08-07→ Ordinary Shares (4,500 underlying) - Exercise/Conversion
Ordinary Shares
2023-06-08$81.76/sh+4,500$367,920→ 1,169,300 total
Footnotes (1)
- [F1]This non-qualified stock option was granted on August 8, 2013 and vested over a period of one year from September 1, 2013. The options were fully vested as of August 1, 2014.